[Skip to content]

Enter search here...
Worcestershire Treatment Pathways

Prevention and control of BBV infections in the Haemodialysis Unit

This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances of the individual patient in consultation with the patient and /or carer.  Health care professionals must be prepared to justify any deviation from this guidance.

Prevention BBV image
Image Map

Pathway Information

Patients receiving haemodialysis are a particularly high risk group for blood-borne virus (BBV) infections. This is because of repetitive access to the vascular system since the Rosenheim Advisory Group issued good practice guidelines to prevent the transmission of hepatitis B in 1972, new BBV’s have emerged such as hepatitis C (HCV) and human immunodeficiency virus (HIV). This has since prompted further investigation into understanding such diseases in order to develop effective evidence based systems and protocols to reduce the transmission of all health care associated infections (HCAI) to patients and staff

This Guideline is for use by the following staff groups:

Although this guideline was developed for staff and patients within the haemodialysis environment, the detail enclosed can be utilised in most all environments where there is a risk of BBV transmission. Doctors, students, relatives, visitors and any person visiting or working within the haemodialysis environment are responsible for following all infection prevention policies and likewise must adhere to this guideline.

Key Documents

New patient commencing haemodialysis (HD)

Routine BBV screening

HBV immunisation 

Page last updated: 28 December 2017